GLP-T — Dual-Pathway Metabolic Peptide
Fat loss • Glucose control • Appetite regulation • Body recomposition
GLP-T is a next-generation dual receptor agonist that activates both GLP-1 and GIP pathways — the two master systems that control hunger, insulin response, and energy balance. This dual-action design allows GLP-T to deliver significantly greater metabolic impact than traditional GLP-1 peptides.
Rather than simply suppressing appetite, GLP-T works by optimizing how the body processes nutrients, stores fat, and utilizes glucose, creating a powerful environment for sustained fat loss and metabolic stability.
In laboratory and clinical research, Tirzepatide has demonstrated the ability to:
• Reduce appetite and food cravings • Enhance insulin sensitivity • Lower blood glucose levels • Preserve lean muscle mass • Promote significant fat loss • Reduce visceral (abdominal) fat
This makes GLP-T one of the most widely studied and effective compounds for weight management, metabolic health, and body recomposition.
Why GLP-T is different
GLP-T does not rely on appetite suppression alone — it reshapes metabolic signaling.
By activating both GLP-1 and GIP receptors, it improves how the body:
• Absorbs and utilizes nutrients • Controls blood sugar • Signals fullness • Stores or releases fat • Maintains metabolic efficiency
The result is more fat loss with less metabolic slowdown, compared to single-pathway peptides.
Studied in research to support
• Obesity and metabolic syndrome • Type-2 diabetes • Insulin resistance • Visceral fat reduction • Cardiovascular risk reduction • Long-term weight control
Clinical trials have shown average body-weight reductions of 15–22% in long-term use — making GLP-T a leading compound in modern metabolic research.
PHP™ Research Performance Standard
Our GLP-T is supplied as a research-grade lyophilized peptide produced in GMP-certified facilities and independently verified for:
✔ Identity ✔ Purity ✔ Potency ✔ Endotoxin levels
Because at PHP™, we believe in Pure Science. Raw Power.
